ReviewMultiple sclerosis (Houndmills, Basingstoke, England)2022

Measuring the cost-effectiveness of treatments for people with multiple sclerosis: Beyond quality-adjusted life-years.

Annie Hawton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.